Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Machiko Arita

Showing results (11-20 of 67) with videos related to

Pageof 7
Sort By:
Journal of Thoracic Disease|February 13, 2019
Cyclosporin A in idiopathic chronic fibrosing interstitial pneumonia without idiopathic pulmonary fibrosisReoto Takei, Machiko Arita, Fumiaki Tokioka, et al.
Clinical Chemistry and Laboratory Medicine|May 24, 2019
Utility of procalcitonin for differentiating cryptogenic organising pneumonia from community-acquired pneumoniaAkihiro Ito, Tadashi Ishida, Hiromasa Tachibana, et al.
Internal Medicine (Tokyo, Japan)|May 12, 2012
Drug-induced interstitial pneumonitis due to low-dose lenalidomideKei Kunimasa, Tomoaki Ueda, Machiko Arita, et al.
Respiratory Medicine Case Reports|January 18, 2021
Acute onset systemic lupus erythematosus interstitial lung disease: A case reportHiroshi Kobe, Machiko Arita, Keiichiro Kadoba, et al.
Stem Cell Research & Therapy|February 14, 2014
Human adipose-derived stem cell transplantation as a potential therapy for collagen VI-related congenital muscular dystrophyVitali Alexeev, Machiko Arita, Adele Donahue, et al.
Respiratory Investigation|June 21, 2025
Risk factors for the onset of pneumothorax in idiopathic pulmonary fibrosisRyoju Sato, Machiko Arita, Hiroshi Takahashi, et al.
BMC Pulmonary Medicine|May 13, 2026
Anti-Ro-52 antibody is a risk factor for recurrence in interstitial lung disease with positive anti-aminoacyl tRNA synthetase antibody: a single-center, retrospective observational studyHiroshi Takahashi, Machiko Arita, Ryoju Sato, et al.
Kansenshogaku Zasshi. the Journal of the Japanese Association for Infectious Diseases|February 21, 2002
[An autopsied case of septicemia due to Vibrio vulnificus]Makoto Osawa, Masahiro Tachibana, Machiko Arita, et al.
Internal Medicine (Tokyo, Japan)|February 15, 2021
Acute Pulmonary Graft-Versus-Host Disease in a Patient with Adult T-cell Leukemia-Lymphoma Diagnosed by a CryobiopsyHiroshi Kobe, Machiko Arita, Takeshi Maeda, et al.
BMC Pulmonary Medicine|April 22, 2017
Impact of lymphocyte differential count > 15% in BALF on the mortality of patients with acute exacerbation of chronic fibrosing idiopathic interstitial pneumoniaReoto Takei, Machiko Arita, Shogo Kumagai, et al.
Pageof 7

Showing results (11-20 of 67) with videos related to

Sort By:
Pageof 7
Journal of Thoracic Disease|February 13, 2019
Cyclosporin A in idiopathic chronic fibrosing interstitial pneumonia without idiopathic pulmonary fibrosisReoto Takei, Machiko Arita, Fumiaki Tokioka, et al.
Clinical Chemistry and Laboratory Medicine|May 24, 2019
Utility of procalcitonin for differentiating cryptogenic organising pneumonia from community-acquired pneumoniaAkihiro Ito, Tadashi Ishida, Hiromasa Tachibana, et al.
Internal Medicine (Tokyo, Japan)|May 12, 2012
Drug-induced interstitial pneumonitis due to low-dose lenalidomideKei Kunimasa, Tomoaki Ueda, Machiko Arita, et al.
Respiratory Medicine Case Reports|January 18, 2021
Acute onset systemic lupus erythematosus interstitial lung disease: A case reportHiroshi Kobe, Machiko Arita, Keiichiro Kadoba, et al.
Stem Cell Research & Therapy|February 14, 2014
Human adipose-derived stem cell transplantation as a potential therapy for collagen VI-related congenital muscular dystrophyVitali Alexeev, Machiko Arita, Adele Donahue, et al.
Respiratory Investigation|June 21, 2025
Risk factors for the onset of pneumothorax in idiopathic pulmonary fibrosisRyoju Sato, Machiko Arita, Hiroshi Takahashi, et al.
BMC Pulmonary Medicine|May 13, 2026
Anti-Ro-52 antibody is a risk factor for recurrence in interstitial lung disease with positive anti-aminoacyl tRNA synthetase antibody: a single-center, retrospective observational studyHiroshi Takahashi, Machiko Arita, Ryoju Sato, et al.
Kansenshogaku Zasshi. the Journal of the Japanese Association for Infectious Diseases|February 21, 2002
[An autopsied case of septicemia due to Vibrio vulnificus]Makoto Osawa, Masahiro Tachibana, Machiko Arita, et al.
Internal Medicine (Tokyo, Japan)|February 15, 2021
Acute Pulmonary Graft-Versus-Host Disease in a Patient with Adult T-cell Leukemia-Lymphoma Diagnosed by a CryobiopsyHiroshi Kobe, Machiko Arita, Takeshi Maeda, et al.
BMC Pulmonary Medicine|April 22, 2017
Impact of lymphocyte differential count > 15% in BALF on the mortality of patients with acute exacerbation of chronic fibrosing idiopathic interstitial pneumoniaReoto Takei, Machiko Arita, Shogo Kumagai, et al.
Pageof 7